Global Prescription Digital Therapeutic Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Prescription Digital Therapeutic market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Prescription Digital Therapeutic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Digital Therapeutic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Digital Therapeutic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Digital Therapeutic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Better Therapeutics, BigHealth, Biofourmis, Click Therapeutics and Happify, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Prescription Digital Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Prescription Digital Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prescription Digital Therapeutic, with revenue, gross margin and global market share of Prescription Digital Therapeutic from 2018 to 2023.
Chapter 3, the Prescription Digital Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Prescription Digital Therapeutic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Digital Therapeutic.
Chapter 13, to describe Prescription Digital Therapeutic research findings and conclusion.
This report is a detailed and comprehensive analysis for global Prescription Digital Therapeutic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Digital Therapeutic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Digital Therapeutic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Digital Therapeutic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Better Therapeutics, BigHealth, Biofourmis, Click Therapeutics and Happify, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Prescription Digital Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Outpatient Treatment
- Monotherapy
- Hospitals
- Specialty Clinics
- Others
- Better Therapeutics
- BigHealth
- Biofourmis
- Click Therapeutics
- Happify
- Limbix Health
- Medtronic
- NuvoAir AB
- Omada Health
- Pear Therapeutics
- ResMed
- SAMSUNGHEALTHCARE
- Sensyne Health
- Solera Network
- Voluntis
- Welldoc’s Bluestar
- Xealth
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Prescription Digital Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prescription Digital Therapeutic, with revenue, gross margin and global market share of Prescription Digital Therapeutic from 2018 to 2023.
Chapter 3, the Prescription Digital Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Prescription Digital Therapeutic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Digital Therapeutic.
Chapter 13, to describe Prescription Digital Therapeutic research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Prescription Digital Therapeutic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prescription Digital Therapeutic by Type
1.3.1 Overview: Global Prescription Digital Therapeutic Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Prescription Digital Therapeutic Consumption Value Market Share by Type in 2022
1.3.3 Outpatient Treatment
1.3.4 Monotherapy
1.4 Global Prescription Digital Therapeutic Market by Application
1.4.1 Overview: Global Prescription Digital Therapeutic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Others
1.5 Global Prescription Digital Therapeutic Market Size & Forecast
1.6 Global Prescription Digital Therapeutic Market Size and Forecast by Region
1.6.1 Global Prescription Digital Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Prescription Digital Therapeutic Market Size by Region, (2018-2029)
1.6.3 North America Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.4 Europe Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.6 South America Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Better Therapeutics
2.1.1 Better Therapeutics Details
2.1.2 Better Therapeutics Major Business
2.1.3 Better Therapeutics Prescription Digital Therapeutic Product and Solutions
2.1.4 Better Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Better Therapeutics Recent Developments and Future Plans
2.2 BigHealth
2.2.1 BigHealth Details
2.2.2 BigHealth Major Business
2.2.3 BigHealth Prescription Digital Therapeutic Product and Solutions
2.2.4 BigHealth Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BigHealth Recent Developments and Future Plans
2.3 Biofourmis
2.3.1 Biofourmis Details
2.3.2 Biofourmis Major Business
2.3.3 Biofourmis Prescription Digital Therapeutic Product and Solutions
2.3.4 Biofourmis Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biofourmis Recent Developments and Future Plans
2.4 Click Therapeutics
2.4.1 Click Therapeutics Details
2.4.2 Click Therapeutics Major Business
2.4.3 Click Therapeutics Prescription Digital Therapeutic Product and Solutions
2.4.4 Click Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Click Therapeutics Recent Developments and Future Plans
2.5 Happify
2.5.1 Happify Details
2.5.2 Happify Major Business
2.5.3 Happify Prescription Digital Therapeutic Product and Solutions
2.5.4 Happify Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Happify Recent Developments and Future Plans
2.6 Limbix Health
2.6.1 Limbix Health Details
2.6.2 Limbix Health Major Business
2.6.3 Limbix Health Prescription Digital Therapeutic Product and Solutions
2.6.4 Limbix Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Limbix Health Recent Developments and Future Plans
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Prescription Digital Therapeutic Product and Solutions
2.7.4 Medtronic Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Medtronic Recent Developments and Future Plans
2.8 NuvoAir AB
2.8.1 NuvoAir AB Details
2.8.2 NuvoAir AB Major Business
2.8.3 NuvoAir AB Prescription Digital Therapeutic Product and Solutions
2.8.4 NuvoAir AB Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NuvoAir AB Recent Developments and Future Plans
2.9 Omada Health
2.9.1 Omada Health Details
2.9.2 Omada Health Major Business
2.9.3 Omada Health Prescription Digital Therapeutic Product and Solutions
2.9.4 Omada Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Omada Health Recent Developments and Future Plans
2.10 Pear Therapeutics
2.10.1 Pear Therapeutics Details
2.10.2 Pear Therapeutics Major Business
2.10.3 Pear Therapeutics Prescription Digital Therapeutic Product and Solutions
2.10.4 Pear Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pear Therapeutics Recent Developments and Future Plans
2.11 ResMed
2.11.1 ResMed Details
2.11.2 ResMed Major Business
2.11.3 ResMed Prescription Digital Therapeutic Product and Solutions
2.11.4 ResMed Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ResMed Recent Developments and Future Plans
2.12 SAMSUNGHEALTHCARE
2.12.1 SAMSUNGHEALTHCARE Details
2.12.2 SAMSUNGHEALTHCARE Major Business
2.12.3 SAMSUNGHEALTHCARE Prescription Digital Therapeutic Product and Solutions
2.12.4 SAMSUNGHEALTHCARE Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SAMSUNGHEALTHCARE Recent Developments and Future Plans
2.13 Sensyne Health
2.13.1 Sensyne Health Details
2.13.2 Sensyne Health Major Business
2.13.3 Sensyne Health Prescription Digital Therapeutic Product and Solutions
2.13.4 Sensyne Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sensyne Health Recent Developments and Future Plans
2.14 Solera Network
2.14.1 Solera Network Details
2.14.2 Solera Network Major Business
2.14.3 Solera Network Prescription Digital Therapeutic Product and Solutions
2.14.4 Solera Network Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Solera Network Recent Developments and Future Plans
2.15 Voluntis
2.15.1 Voluntis Details
2.15.2 Voluntis Major Business
2.15.3 Voluntis Prescription Digital Therapeutic Product and Solutions
2.15.4 Voluntis Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Voluntis Recent Developments and Future Plans
2.16 Welldoc’s Bluestar
2.16.1 Welldoc’s Bluestar Details
2.16.2 Welldoc’s Bluestar Major Business
2.16.3 Welldoc’s Bluestar Prescription Digital Therapeutic Product and Solutions
2.16.4 Welldoc’s Bluestar Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Welldoc’s Bluestar Recent Developments and Future Plans
2.17 Xealth
2.17.1 Xealth Details
2.17.2 Xealth Major Business
2.17.3 Xealth Prescription Digital Therapeutic Product and Solutions
2.17.4 Xealth Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Xealth Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Prescription Digital Therapeutic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Prescription Digital Therapeutic by Company Revenue
3.2.2 Top 3 Prescription Digital Therapeutic Players Market Share in 2022
3.2.3 Top 6 Prescription Digital Therapeutic Players Market Share in 2022
3.3 Prescription Digital Therapeutic Market: Overall Company Footprint Analysis
3.3.1 Prescription Digital Therapeutic Market: Region Footprint
3.3.2 Prescription Digital Therapeutic Market: Company Product Type Footprint
3.3.3 Prescription Digital Therapeutic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Prescription Digital Therapeutic Consumption Value and Market Share by Type (2018-2023)
4.2 Global Prescription Digital Therapeutic Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2023)
5.2 Global Prescription Digital Therapeutic Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
6.2 North America Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
6.3 North America Prescription Digital Therapeutic Market Size by Country
6.3.1 North America Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
6.3.2 United States Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
6.3.3 Canada Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
6.3.4 Mexico Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
7.2 Europe Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
7.3 Europe Prescription Digital Therapeutic Market Size by Country
7.3.1 Europe Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
7.3.2 Germany Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.3 France Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.5 Russia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.6 Italy Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Prescription Digital Therapeutic Market Size by Region
8.3.1 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2018-2029)
8.3.2 China Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.3 Japan Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.4 South Korea Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.5 India Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.7 Australia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
9.2 South America Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
9.3 South America Prescription Digital Therapeutic Market Size by Country
9.3.1 South America Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
9.3.2 Brazil Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
9.3.3 Argentina Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Prescription Digital Therapeutic Market Size by Country
10.3.1 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
10.3.2 Turkey Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
10.3.4 UAE Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Prescription Digital Therapeutic Market Drivers
11.2 Prescription Digital Therapeutic Market Restraints
11.3 Prescription Digital Therapeutic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Prescription Digital Therapeutic Industry Chain
12.2 Prescription Digital Therapeutic Upstream Analysis
12.3 Prescription Digital Therapeutic Midstream Analysis
12.4 Prescription Digital Therapeutic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Prescription Digital Therapeutic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prescription Digital Therapeutic by Type
1.3.1 Overview: Global Prescription Digital Therapeutic Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Prescription Digital Therapeutic Consumption Value Market Share by Type in 2022
1.3.3 Outpatient Treatment
1.3.4 Monotherapy
1.4 Global Prescription Digital Therapeutic Market by Application
1.4.1 Overview: Global Prescription Digital Therapeutic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Others
1.5 Global Prescription Digital Therapeutic Market Size & Forecast
1.6 Global Prescription Digital Therapeutic Market Size and Forecast by Region
1.6.1 Global Prescription Digital Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Prescription Digital Therapeutic Market Size by Region, (2018-2029)
1.6.3 North America Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.4 Europe Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.6 South America Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Better Therapeutics
2.1.1 Better Therapeutics Details
2.1.2 Better Therapeutics Major Business
2.1.3 Better Therapeutics Prescription Digital Therapeutic Product and Solutions
2.1.4 Better Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Better Therapeutics Recent Developments and Future Plans
2.2 BigHealth
2.2.1 BigHealth Details
2.2.2 BigHealth Major Business
2.2.3 BigHealth Prescription Digital Therapeutic Product and Solutions
2.2.4 BigHealth Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BigHealth Recent Developments and Future Plans
2.3 Biofourmis
2.3.1 Biofourmis Details
2.3.2 Biofourmis Major Business
2.3.3 Biofourmis Prescription Digital Therapeutic Product and Solutions
2.3.4 Biofourmis Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biofourmis Recent Developments and Future Plans
2.4 Click Therapeutics
2.4.1 Click Therapeutics Details
2.4.2 Click Therapeutics Major Business
2.4.3 Click Therapeutics Prescription Digital Therapeutic Product and Solutions
2.4.4 Click Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Click Therapeutics Recent Developments and Future Plans
2.5 Happify
2.5.1 Happify Details
2.5.2 Happify Major Business
2.5.3 Happify Prescription Digital Therapeutic Product and Solutions
2.5.4 Happify Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Happify Recent Developments and Future Plans
2.6 Limbix Health
2.6.1 Limbix Health Details
2.6.2 Limbix Health Major Business
2.6.3 Limbix Health Prescription Digital Therapeutic Product and Solutions
2.6.4 Limbix Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Limbix Health Recent Developments and Future Plans
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Prescription Digital Therapeutic Product and Solutions
2.7.4 Medtronic Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Medtronic Recent Developments and Future Plans
2.8 NuvoAir AB
2.8.1 NuvoAir AB Details
2.8.2 NuvoAir AB Major Business
2.8.3 NuvoAir AB Prescription Digital Therapeutic Product and Solutions
2.8.4 NuvoAir AB Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NuvoAir AB Recent Developments and Future Plans
2.9 Omada Health
2.9.1 Omada Health Details
2.9.2 Omada Health Major Business
2.9.3 Omada Health Prescription Digital Therapeutic Product and Solutions
2.9.4 Omada Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Omada Health Recent Developments and Future Plans
2.10 Pear Therapeutics
2.10.1 Pear Therapeutics Details
2.10.2 Pear Therapeutics Major Business
2.10.3 Pear Therapeutics Prescription Digital Therapeutic Product and Solutions
2.10.4 Pear Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pear Therapeutics Recent Developments and Future Plans
2.11 ResMed
2.11.1 ResMed Details
2.11.2 ResMed Major Business
2.11.3 ResMed Prescription Digital Therapeutic Product and Solutions
2.11.4 ResMed Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ResMed Recent Developments and Future Plans
2.12 SAMSUNGHEALTHCARE
2.12.1 SAMSUNGHEALTHCARE Details
2.12.2 SAMSUNGHEALTHCARE Major Business
2.12.3 SAMSUNGHEALTHCARE Prescription Digital Therapeutic Product and Solutions
2.12.4 SAMSUNGHEALTHCARE Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SAMSUNGHEALTHCARE Recent Developments and Future Plans
2.13 Sensyne Health
2.13.1 Sensyne Health Details
2.13.2 Sensyne Health Major Business
2.13.3 Sensyne Health Prescription Digital Therapeutic Product and Solutions
2.13.4 Sensyne Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sensyne Health Recent Developments and Future Plans
2.14 Solera Network
2.14.1 Solera Network Details
2.14.2 Solera Network Major Business
2.14.3 Solera Network Prescription Digital Therapeutic Product and Solutions
2.14.4 Solera Network Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Solera Network Recent Developments and Future Plans
2.15 Voluntis
2.15.1 Voluntis Details
2.15.2 Voluntis Major Business
2.15.3 Voluntis Prescription Digital Therapeutic Product and Solutions
2.15.4 Voluntis Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Voluntis Recent Developments and Future Plans
2.16 Welldoc’s Bluestar
2.16.1 Welldoc’s Bluestar Details
2.16.2 Welldoc’s Bluestar Major Business
2.16.3 Welldoc’s Bluestar Prescription Digital Therapeutic Product and Solutions
2.16.4 Welldoc’s Bluestar Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Welldoc’s Bluestar Recent Developments and Future Plans
2.17 Xealth
2.17.1 Xealth Details
2.17.2 Xealth Major Business
2.17.3 Xealth Prescription Digital Therapeutic Product and Solutions
2.17.4 Xealth Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Xealth Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Prescription Digital Therapeutic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Prescription Digital Therapeutic by Company Revenue
3.2.2 Top 3 Prescription Digital Therapeutic Players Market Share in 2022
3.2.3 Top 6 Prescription Digital Therapeutic Players Market Share in 2022
3.3 Prescription Digital Therapeutic Market: Overall Company Footprint Analysis
3.3.1 Prescription Digital Therapeutic Market: Region Footprint
3.3.2 Prescription Digital Therapeutic Market: Company Product Type Footprint
3.3.3 Prescription Digital Therapeutic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Prescription Digital Therapeutic Consumption Value and Market Share by Type (2018-2023)
4.2 Global Prescription Digital Therapeutic Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2023)
5.2 Global Prescription Digital Therapeutic Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
6.2 North America Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
6.3 North America Prescription Digital Therapeutic Market Size by Country
6.3.1 North America Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
6.3.2 United States Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
6.3.3 Canada Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
6.3.4 Mexico Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
7.2 Europe Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
7.3 Europe Prescription Digital Therapeutic Market Size by Country
7.3.1 Europe Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
7.3.2 Germany Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.3 France Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.5 Russia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
7.3.6 Italy Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Prescription Digital Therapeutic Market Size by Region
8.3.1 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2018-2029)
8.3.2 China Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.3 Japan Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.4 South Korea Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.5 India Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
8.3.7 Australia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
9.2 South America Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
9.3 South America Prescription Digital Therapeutic Market Size by Country
9.3.1 South America Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
9.3.2 Brazil Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
9.3.3 Argentina Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Prescription Digital Therapeutic Market Size by Country
10.3.1 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
10.3.2 Turkey Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
10.3.4 UAE Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Prescription Digital Therapeutic Market Drivers
11.2 Prescription Digital Therapeutic Market Restraints
11.3 Prescription Digital Therapeutic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Prescription Digital Therapeutic Industry Chain
12.2 Prescription Digital Therapeutic Upstream Analysis
12.3 Prescription Digital Therapeutic Midstream Analysis
12.4 Prescription Digital Therapeutic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Prescription Digital Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prescription Digital Therapeutic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Prescription Digital Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Prescription Digital Therapeutic Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Better Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Better Therapeutics Major Business
Table 7. Better Therapeutics Prescription Digital Therapeutic Product and Solutions
Table 8. Better Therapeutics Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Better Therapeutics Recent Developments and Future Plans
Table 10. BigHealth Company Information, Head Office, and Major Competitors
Table 11. BigHealth Major Business
Table 12. BigHealth Prescription Digital Therapeutic Product and Solutions
Table 13. BigHealth Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BigHealth Recent Developments and Future Plans
Table 15. Biofourmis Company Information, Head Office, and Major Competitors
Table 16. Biofourmis Major Business
Table 17. Biofourmis Prescription Digital Therapeutic Product and Solutions
Table 18. Biofourmis Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biofourmis Recent Developments and Future Plans
Table 20. Click Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Click Therapeutics Major Business
Table 22. Click Therapeutics Prescription Digital Therapeutic Product and Solutions
Table 23. Click Therapeutics Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Click Therapeutics Recent Developments and Future Plans
Table 25. Happify Company Information, Head Office, and Major Competitors
Table 26. Happify Major Business
Table 27. Happify Prescription Digital Therapeutic Product and Solutions
Table 28. Happify Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Happify Recent Developments and Future Plans
Table 30. Limbix Health Company Information, Head Office, and Major Competitors
Table 31. Limbix Health Major Business
Table 32. Limbix Health Prescription Digital Therapeutic Product and Solutions
Table 33. Limbix Health Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Limbix Health Recent Developments and Future Plans
Table 35. Medtronic Company Information, Head Office, and Major Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Prescription Digital Therapeutic Product and Solutions
Table 38. Medtronic Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Medtronic Recent Developments and Future Plans
Table 40. NuvoAir AB Company Information, Head Office, and Major Competitors
Table 41. NuvoAir AB Major Business
Table 42. NuvoAir AB Prescription Digital Therapeutic Product and Solutions
Table 43. NuvoAir AB Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. NuvoAir AB Recent Developments and Future Plans
Table 45. Omada Health Company Information, Head Office, and Major Competitors
Table 46. Omada Health Major Business
Table 47. Omada Health Prescription Digital Therapeutic Product and Solutions
Table 48. Omada Health Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Omada Health Recent Developments and Future Plans
Table 50. Pear Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Pear Therapeutics Major Business
Table 52. Pear Therapeutics Prescription Digital Therapeutic Product and Solutions
Table 53. Pear Therapeutics Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pear Therapeutics Recent Developments and Future Plans
Table 55. ResMed Company Information, Head Office, and Major Competitors
Table 56. ResMed Major Business
Table 57. ResMed Prescription Digital Therapeutic Product and Solutions
Table 58. ResMed Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. ResMed Recent Developments and Future Plans
Table 60. SAMSUNGHEALTHCARE Company Information, Head Office, and Major Competitors
Table 61. SAMSUNGHEALTHCARE Major Business
Table 62. SAMSUNGHEALTHCARE Prescription Digital Therapeutic Product and Solutions
Table 63. SAMSUNGHEALTHCARE Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. SAMSUNGHEALTHCARE Recent Developments and Future Plans
Table 65. Sensyne Health Company Information, Head Office, and Major Competitors
Table 66. Sensyne Health Major Business
Table 67. Sensyne Health Prescription Digital Therapeutic Product and Solutions
Table 68. Sensyne Health Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Sensyne Health Recent Developments and Future Plans
Table 70. Solera Network Company Information, Head Office, and Major Competitors
Table 71. Solera Network Major Business
Table 72. Solera Network Prescription Digital Therapeutic Product and Solutions
Table 73. Solera Network Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Solera Network Recent Developments and Future Plans
Table 75. Voluntis Company Information, Head Office, and Major Competitors
Table 76. Voluntis Major Business
Table 77. Voluntis Prescription Digital Therapeutic Product and Solutions
Table 78. Voluntis Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Voluntis Recent Developments and Future Plans
Table 80. Welldoc’s Bluestar Company Information, Head Office, and Major Competitors
Table 81. Welldoc’s Bluestar Major Business
Table 82. Welldoc’s Bluestar Prescription Digital Therapeutic Product and Solutions
Table 83. Welldoc’s Bluestar Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Welldoc’s Bluestar Recent Developments and Future Plans
Table 85. Xealth Company Information, Head Office, and Major Competitors
Table 86. Xealth Major Business
Table 87. Xealth Prescription Digital Therapeutic Product and Solutions
Table 88. Xealth Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Xealth Recent Developments and Future Plans
Table 90. Global Prescription Digital Therapeutic Revenue (USD Million) by Players (2018-2023)
Table 91. Global Prescription Digital Therapeutic Revenue Share by Players (2018-2023)
Table 92. Breakdown of Prescription Digital Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Prescription Digital Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Prescription Digital Therapeutic Players
Table 95. Prescription Digital Therapeutic Market: Company Product Type Footprint
Table 96. Prescription Digital Therapeutic Market: Company Product Application Footprint
Table 97. Prescription Digital Therapeutic New Market Entrants and Barriers to Market Entry
Table 98. Prescription Digital Therapeutic Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Prescription Digital Therapeutic Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Prescription Digital Therapeutic Consumption Value Share by Type (2018-2023)
Table 101. Global Prescription Digital Therapeutic Consumption Value Forecast by Type (2024-2029)
Table 102. Global Prescription Digital Therapeutic Consumption Value by Application (2018-2023)
Table 103. Global Prescription Digital Therapeutic Consumption Value Forecast by Application (2024-2029)
Table 104. North America Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Prescription Digital Therapeutic Raw Material
Table 135. Key Suppliers of Prescription Digital Therapeutic Raw Materials
Table 1. Global Prescription Digital Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prescription Digital Therapeutic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Prescription Digital Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Prescription Digital Therapeutic Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Better Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Better Therapeutics Major Business
Table 7. Better Therapeutics Prescription Digital Therapeutic Product and Solutions
Table 8. Better Therapeutics Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Better Therapeutics Recent Developments and Future Plans
Table 10. BigHealth Company Information, Head Office, and Major Competitors
Table 11. BigHealth Major Business
Table 12. BigHealth Prescription Digital Therapeutic Product and Solutions
Table 13. BigHealth Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BigHealth Recent Developments and Future Plans
Table 15. Biofourmis Company Information, Head Office, and Major Competitors
Table 16. Biofourmis Major Business
Table 17. Biofourmis Prescription Digital Therapeutic Product and Solutions
Table 18. Biofourmis Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biofourmis Recent Developments and Future Plans
Table 20. Click Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Click Therapeutics Major Business
Table 22. Click Therapeutics Prescription Digital Therapeutic Product and Solutions
Table 23. Click Therapeutics Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Click Therapeutics Recent Developments and Future Plans
Table 25. Happify Company Information, Head Office, and Major Competitors
Table 26. Happify Major Business
Table 27. Happify Prescription Digital Therapeutic Product and Solutions
Table 28. Happify Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Happify Recent Developments and Future Plans
Table 30. Limbix Health Company Information, Head Office, and Major Competitors
Table 31. Limbix Health Major Business
Table 32. Limbix Health Prescription Digital Therapeutic Product and Solutions
Table 33. Limbix Health Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Limbix Health Recent Developments and Future Plans
Table 35. Medtronic Company Information, Head Office, and Major Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Prescription Digital Therapeutic Product and Solutions
Table 38. Medtronic Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Medtronic Recent Developments and Future Plans
Table 40. NuvoAir AB Company Information, Head Office, and Major Competitors
Table 41. NuvoAir AB Major Business
Table 42. NuvoAir AB Prescription Digital Therapeutic Product and Solutions
Table 43. NuvoAir AB Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. NuvoAir AB Recent Developments and Future Plans
Table 45. Omada Health Company Information, Head Office, and Major Competitors
Table 46. Omada Health Major Business
Table 47. Omada Health Prescription Digital Therapeutic Product and Solutions
Table 48. Omada Health Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Omada Health Recent Developments and Future Plans
Table 50. Pear Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Pear Therapeutics Major Business
Table 52. Pear Therapeutics Prescription Digital Therapeutic Product and Solutions
Table 53. Pear Therapeutics Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pear Therapeutics Recent Developments and Future Plans
Table 55. ResMed Company Information, Head Office, and Major Competitors
Table 56. ResMed Major Business
Table 57. ResMed Prescription Digital Therapeutic Product and Solutions
Table 58. ResMed Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. ResMed Recent Developments and Future Plans
Table 60. SAMSUNGHEALTHCARE Company Information, Head Office, and Major Competitors
Table 61. SAMSUNGHEALTHCARE Major Business
Table 62. SAMSUNGHEALTHCARE Prescription Digital Therapeutic Product and Solutions
Table 63. SAMSUNGHEALTHCARE Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. SAMSUNGHEALTHCARE Recent Developments and Future Plans
Table 65. Sensyne Health Company Information, Head Office, and Major Competitors
Table 66. Sensyne Health Major Business
Table 67. Sensyne Health Prescription Digital Therapeutic Product and Solutions
Table 68. Sensyne Health Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Sensyne Health Recent Developments and Future Plans
Table 70. Solera Network Company Information, Head Office, and Major Competitors
Table 71. Solera Network Major Business
Table 72. Solera Network Prescription Digital Therapeutic Product and Solutions
Table 73. Solera Network Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Solera Network Recent Developments and Future Plans
Table 75. Voluntis Company Information, Head Office, and Major Competitors
Table 76. Voluntis Major Business
Table 77. Voluntis Prescription Digital Therapeutic Product and Solutions
Table 78. Voluntis Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Voluntis Recent Developments and Future Plans
Table 80. Welldoc’s Bluestar Company Information, Head Office, and Major Competitors
Table 81. Welldoc’s Bluestar Major Business
Table 82. Welldoc’s Bluestar Prescription Digital Therapeutic Product and Solutions
Table 83. Welldoc’s Bluestar Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Welldoc’s Bluestar Recent Developments and Future Plans
Table 85. Xealth Company Information, Head Office, and Major Competitors
Table 86. Xealth Major Business
Table 87. Xealth Prescription Digital Therapeutic Product and Solutions
Table 88. Xealth Prescription Digital Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Xealth Recent Developments and Future Plans
Table 90. Global Prescription Digital Therapeutic Revenue (USD Million) by Players (2018-2023)
Table 91. Global Prescription Digital Therapeutic Revenue Share by Players (2018-2023)
Table 92. Breakdown of Prescription Digital Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Prescription Digital Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Prescription Digital Therapeutic Players
Table 95. Prescription Digital Therapeutic Market: Company Product Type Footprint
Table 96. Prescription Digital Therapeutic Market: Company Product Application Footprint
Table 97. Prescription Digital Therapeutic New Market Entrants and Barriers to Market Entry
Table 98. Prescription Digital Therapeutic Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Prescription Digital Therapeutic Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Prescription Digital Therapeutic Consumption Value Share by Type (2018-2023)
Table 101. Global Prescription Digital Therapeutic Consumption Value Forecast by Type (2024-2029)
Table 102. Global Prescription Digital Therapeutic Consumption Value by Application (2018-2023)
Table 103. Global Prescription Digital Therapeutic Consumption Value Forecast by Application (2024-2029)
Table 104. North America Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Prescription Digital Therapeutic Raw Material
Table 135. Key Suppliers of Prescription Digital Therapeutic Raw Materials
LIST OF FIGURES
Figure 1. Prescription Digital Therapeutic Picture
Figure 2. Global Prescription Digital Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prescription Digital Therapeutic Consumption Value Market Share by Type in 2022
Figure 4. Outpatient Treatment
Figure 5. Monotherapy
Figure 6. Global Prescription Digital Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Prescription Digital Therapeutic Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Picture
Figure 9. Specialty Clinics Picture
Figure 10. Others Picture
Figure 11. Global Prescription Digital Therapeutic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Prescription Digital Therapeutic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Prescription Digital Therapeutic Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Prescription Digital Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Prescription Digital Therapeutic Consumption Value Market Share by Region in 2022
Figure 16. North America Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Prescription Digital Therapeutic Revenue Share by Players in 2022
Figure 22. Prescription Digital Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Prescription Digital Therapeutic Market Share in 2022
Figure 24. Global Top 6 Players Prescription Digital Therapeutic Market Share in 2022
Figure 25. Global Prescription Digital Therapeutic Consumption Value Share by Type (2018-2023)
Figure 26. Global Prescription Digital Therapeutic Market Share Forecast by Type (2024-2029)
Figure 27. Global Prescription Digital Therapeutic Consumption Value Share by Application (2018-2023)
Figure 28. Global Prescription Digital Therapeutic Market Share Forecast by Application (2024-2029)
Figure 29. North America Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 39. France Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Prescription Digital Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 46. China Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 49. India Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 63. Prescription Digital Therapeutic Market Drivers
Figure 64. Prescription Digital Therapeutic Market Restraints
Figure 65. Prescription Digital Therapeutic Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Prescription Digital Therapeutic in 2022
Figure 68. Manufacturing Process Analysis of Prescription Digital Therapeutic
Figure 69. Prescription Digital Therapeutic Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Prescription Digital Therapeutic Picture
Figure 2. Global Prescription Digital Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prescription Digital Therapeutic Consumption Value Market Share by Type in 2022
Figure 4. Outpatient Treatment
Figure 5. Monotherapy
Figure 6. Global Prescription Digital Therapeutic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Prescription Digital Therapeutic Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Picture
Figure 9. Specialty Clinics Picture
Figure 10. Others Picture
Figure 11. Global Prescription Digital Therapeutic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Prescription Digital Therapeutic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Prescription Digital Therapeutic Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Prescription Digital Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Prescription Digital Therapeutic Consumption Value Market Share by Region in 2022
Figure 16. North America Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Prescription Digital Therapeutic Revenue Share by Players in 2022
Figure 22. Prescription Digital Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Prescription Digital Therapeutic Market Share in 2022
Figure 24. Global Top 6 Players Prescription Digital Therapeutic Market Share in 2022
Figure 25. Global Prescription Digital Therapeutic Consumption Value Share by Type (2018-2023)
Figure 26. Global Prescription Digital Therapeutic Market Share Forecast by Type (2024-2029)
Figure 27. Global Prescription Digital Therapeutic Consumption Value Share by Application (2018-2023)
Figure 28. Global Prescription Digital Therapeutic Market Share Forecast by Application (2024-2029)
Figure 29. North America Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 39. France Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Prescription Digital Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 46. China Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 49. India Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Prescription Digital Therapeutic Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Prescription Digital Therapeutic Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Prescription Digital Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 63. Prescription Digital Therapeutic Market Drivers
Figure 64. Prescription Digital Therapeutic Market Restraints
Figure 65. Prescription Digital Therapeutic Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Prescription Digital Therapeutic in 2022
Figure 68. Manufacturing Process Analysis of Prescription Digital Therapeutic
Figure 69. Prescription Digital Therapeutic Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
